Google.org

Merida Biosciences is a biotechnology company specializing in the development of precision therapies for autoimmune diseases. It employs a protein engineering platform to create novel Fc therapeutics, which selectively target and neutralize specific antibodies, aiming to treat the root cause of antibody-driven diseases with high precision and durability.

Layer Health is a technology company specializing in AI-driven healthcare information solutions. It develops an AI-powered platform designed to help healthcare providers extract valuable insights from patient data, enabling them to make informed decisions, enhance patient care, and improve overall efficiency. The platform focuses on processing unstructured data from clinical, administrative, and research sources, transforming it into actionable insights to support providers in their clinical and operational tasks.

Perceive Pharma operates as a pharmaceutical company. Perceive Pharma develops innovative small molecule neuroprotective treatments.

Apptronik is a robotics company focused on creating humanoid robots for a range of practical applications. Their robots are designed to perform tasks traditionally carried out by humans, such as case picking, down stacking, trailer unloading, palletizing, sortation, and heavy lifting. By providing versatile and efficient robotics solutions, Apptronik aims to help industries address labor shortages, improve job satisfaction by taking over less desirable tasks, and enhance overall productivity. The company's innovative approach to robotics manufacturing is tailored to meet the needs of various sectors, making their technology applicable in diverse environments.

Perfumeo is a provider of an innovative home fragrance system that utilizes advanced artificial intelligence to adapt scents based on user moods, creating a personalized fragrance experience. The company's patented technology, verified by Equidam and holding patents in 157 countries, combines AI, data science, green mechatronics, and green chemistry, giving it a significant competitive advantage in the market. After extensive research and development, Perfumeo's V3 functional prototype received positive feedback from focus groups in 2023, indicating strong potential for success. The system not only enhances the sensory experience of homeowners but also emphasizes eco-friendly dispersion methods, aligning with contemporary demands for sustainability in home products.

Rhygaze is focused on developing a novel gene therapy aimed at restoring vision in patients affected by diseases that lead to blindness. The company's innovative technology specifically targets cone cells, which are crucial for light detection but may lose sensitivity due to various conditions. By delivering a light-sensor gene directly to these compromised cone cells, Rhygaze seeks to repair their ability to detect light, thereby offering potential vision restoration solutions for individuals suffering from blindness.

Terradot is a developer of a carbon removal platform focused on reducing carbon footprints and enhancing soil carbon management. The company employs various methods to extract carbon dioxide from the atmosphere and facilitate high-integrity soil carbon removal. This platform enables both businesses and individuals to actively participate in environmental sustainability efforts, contributing to a positive impact on the planet.

Lawhive Associates offers legal services in civil and criminal matters, international arbitration, dispute resolution, and defamation cases.

Lawhive is a legal tech startup that provides an AI-powered platform designed to streamline workflow management, compliance, and payments for legal professionals. This innovative platform allows lawyers to automate various aspects of their work, leading to significant time savings and enhanced efficiency. By offering access to expert solicitors, Lawhive enables financial institutions to obtain real-time risk assessments while minimizing the burdensome processes typically associated with traditional legal services. This approach not only reduces costs for clients but also improves overall service delivery in the legal sector.

Synapticure is a virtual clinical care platform dedicated to supporting patients with neurodegenerative diseases, including dementia, Parkinson's, and ALS, throughout the United States. Founded by patients, the company offers comprehensive care services that include access to disease-specific neurologists, speech and language therapy, and 24/7 care coordination. Utilizing advances in science, technology, and computational analytics, Synapticure ensures that patients receive tailored treatment and support in their own homes. The platform integrates medical, dental, vision, and life insurance plans to facilitate easy access to a range of healthcare services, including behavioral health support such as psychiatry and therapy, all aimed at enhancing the quality of life for individuals facing these challenging conditions.

Tessl is a technology company that specializes in AI-native software development. It offers an AI-powered platform that generates, maintains, and tests code based on user-defined specifications. This platform ensures secure, high-quality, and self-maintaining code, allowing developers to create software that is compatible with emerging AI technologies.

Odyssey operates as an AI start-up, provides hollywood-grade visual AI.

Diverge Health is a healthcare platform designed to support primary care practices in providing quality care to underserved patients. The company enhances these practices by offering a robust infrastructure that includes highly trained community health teams and administrative support. Additionally, Diverge Health integrates technology to facilitate local population health management. This comprehensive approach enables primary care providers to achieve better health outcomes for their patients while successfully navigating the shift towards value-based payment models.

Genie AI Limited is a company based in London, United Kingdom, that specializes in artificial intelligence solutions for the legal sector. It has developed a platform called SuperDrafter, which utilizes machine learning to assist lawyers in drafting contracts more efficiently by leveraging the collective knowledge of their firm. Additionally, Genie AI offers a feature known as Anonymiser that automatically redacts sensitive information from contracts. The company also organizes educational events and training sessions focused on smart contracts and the application of artificial intelligence in legal practices. Founded in 2017, Genie AI aims to enhance the contract drafting process, allowing lawyers to manage client risks and negotiate effectively within tight deadlines.

Rippl Care is a mental health company based in Seattle, Washington, dedicated to supporting seniors experiencing dementia and other neurocognitive disorders. Founded in 2021, the company employs a value-based approach and innovative technology to deliver comprehensive care tailored to individual needs. By prioritizing the empowerment of its clinicians, Rippl Care adopts a novel care model that enables seniors to receive personalized support through various channels, including phone, online, and in-home visits. This commitment to enhancing the quality of care for those affected by neurocognitive conditions sets Rippl Care apart in the mental health landscape.

Wealth.com is a digital estate planning platform that enables individuals to create, manage, and visualize their estate plans in a secure online environment. The platform provides users with a comprehensive view of their assets, which are securely stored and easily accessible. Wealth.com implements advanced asset aggregation technology and robust security measures, including bank-level encryption, to ensure that users can confidently manage their plans. In addition to individual use, Wealth.com offers its services to companies as an employee benefit, promoting financial wellness among employees. The platform also includes features that allow for emergency access by trusted beneficiaries, ensuring that plans remain accessible when needed most.

Pelage Pharma delivers a clinically tested treatment for both men and women battling the emotional pain or social stigma of hair loss. Its non-invasive, topical small molecule drug platform activates hair follicle stem cells and stimulates robust hair growth.

Again operates as a developer of advanced emission control technology that transforms carbon dioxide into valuable chemicals and proteins through a proprietary bacterial process. The company captures CO2 emissions from industrial facilities within a bioreactor, where the bacteria convert the greenhouse gas into products like feed for poultry and aquaculture. This innovative approach not only helps clients reduce their environmental impact but also allows them to avoid costly emission taxes. As a pioneer in carbon negative manufacturing, Again is positioned to meet global demand for sustainable chemical solutions while actively contributing to the fight against climate change.

Climate X is a global climate physical risk data analytics company that specializes in climate risk management services. The firm provides tools to project and predict the impacts of climate change and extreme weather events by integrating climate models with current real-world data. Through its physical modeling capabilities, Climate X enables businesses and governments to anticipate regulatory requirements and adapt to evolving climate-related challenges. Its clientele includes prominent financial institutions in sectors such as banking, real estate, and insurance, highlighting its relevance in a rapidly changing climate landscape.

Verse provides software for organizations to understand, plan, and manage clean energy. Its SaaS platform, Aria™, leverages generative AI to help companies define clean energy goals and plan, procure, and manage optimal portfolios of clean energy assets at least cost. Customers can set parameters that target specific goals (e.g., cost, emissions, or hourly matching) and optimize for annual matching, emissions matching, or hourly matched carbon-free energy (CFE). By reducing transaction costs by up to 70% and providing real-time analysis within minutes, Aria helps scale and accelerate the clean energy transition.

WitnessAI is dedicated to creating a security platform that provides essential governance and security controls for enterprises adopting artificial intelligence. The platform enhances visibility and privacy regarding AI activities, allowing businesses to leverage the benefits of generative AI while maintaining control over their data and ensuring security. By focusing on making AI safe and productive, WitnessAI helps organizations innovate without compromising on privacy or governance.

Delphia Therapeutics, headquartered in Boston, USA, is a biotechnology company focused on developing innovative cancer treatments. It operates a laboratory where researchers study cancer-driving pathways to create targeted therapies. The company's approach involves selectively over-activating certain cancer-linked cell signaling pathways, making tumor cells unsustainable and enabling more effective cancer treatment for patients.

Metsera is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for obesity and metabolic conditions. The company focuses on advancing a variety of oral and injectable treatment options, including incretin, non-incretin, and combination therapies. These treatments are designed to address multiple therapeutic targets, positioning Metsera to meet the evolving demands of the weight loss treatment landscape. Additionally, Metsera integrates proprietary health technology tools to provide personalized care, enhancing the effectiveness of its therapeutic offerings.

Pelage Pharma delivers a clinically tested treatment for both men and women battling the emotional pain or social stigma of hair loss. Its non-invasive, topical small molecule drug platform activates hair follicle stem cells and stimulates robust hair growth.

Lapse is a social disposable camera application that allows users to capture and share photos within private group chats. The app emulates the experience of traditional disposable cameras by enabling groups to take a set of 36 photos, referred to as 'rolls.' Once the first photo is taken, the roll becomes accessible to group members for a limited time, fostering a sense of shared experience and nostalgia. This innovative approach encourages users to engage with friends while creating temporary memories that are exclusive to their group.

Fabric is a health tech company that enables healthcare providers to deliver faster, higher quality, and more accessible care while reducing costs via consumer-grade patient experiences that automate workflows for staff.

Areteia Therapeutics is a biotechnology company focused on improving the management of eosinophilic asthma through an innovative oral drug treatment. The company, which emerged from Knopp, aims to provide patients with a novel therapeutic option that inhibits the maturation of eosinophils—cells that can cause airway damage in asthma patients. Its drug candidate has demonstrated promising results in a phase 2 clinical trial, which showed a reduction in blood eosinophil counts, indicating enhanced lung function. This approach seeks to empower patients by offering a potentially effective and accessible treatment for a severe form of asthma, thereby improving their quality of life and disease management.

Granata Bio is a biotechnology company established in 2018 that specializes in identifying and developing therapeutics for fertility patients. The company focuses on creating a comprehensive portfolio of fertility-related treatments and leverages its expertise in commercialization, late-stage clinical trials, and regulatory development. Granata Bio aims to address significant challenges faced by medical professionals in fertility treatment. Recently, the company announced a partnership with IBSA Institut Biochimique to co-develop a novel subcutaneous progesterone solution, further enhancing its commitment to improving fertility care.

FlutterFlow, established in 2020, is an innovative low-code visual development platform that facilitates the creation of native mobile and web applications. With a user base exceeding 400,000 and a multitude of applications launched in app stores, FlutterFlow enables product teams to design impressive user interfaces and generate clean code efficiently. The platform features a one-click deployment option that accelerates project timelines while allowing for custom code extensions. It supports seamless integration with Firebase and provides a no-code tool for downloading generated Flutter code, making it easier for developers to create cross-platform applications swiftly. By streamlining the application development process, FlutterFlow helps businesses scale rapidly and effectively.

Moonwalk Biosciences is a genomic medicine startup focused on developing precision epigenetic therapeutics. The company is creating a profiling and engineering technology platform that leverages advanced artificial intelligence to deliver an in-depth understanding of the epigenome in both health and disease. This innovative approach allows healthcare providers to explore new avenues for therapy discovery and facilitates the reprogramming of cells to restore their healthy state. By integrating AI-driven insights, Moonwalk Biosciences aims to transform the landscape of therapeutic development and improve patient outcomes.

Essential AI specializes in developing language model-based software that enhances operational efficiency for enterprises. By automating labor-intensive and repetitive workflows, the company provides AI solutions that simplify complex tasks and improve productivity. Essential AI's software utilizes advanced machine learning and artificial intelligence models, enabling organizations to access these technologies in multiple languages. Through a combination of human feedback and technological advancements, the company's solutions empower users to unlock essential skills and amplify their impact on society.

Tome Biosciences is a biotechnology company specializing in programmable gene insertion technology. Utilizing CRISPR, the company develops methods to insert genetic sequences of any size at various locations within any genome. This innovative approach aims to enhance the ability to detect and eliminate deoxyribonucleic acid from similar bacteriophages during infections. By advancing cell and genome engineering, Tome Biosciences seeks to provide effective therapeutic solutions for patients, paving the way for significant advancements in genetic medicine.

Gate Bioscience is a biotechnology company focused on developing small molecule drugs to selectively target and eliminate harmful extracellular proteins at their source within cells. The company's innovative approach combines a proprietary library of molecular gates, specialized assays, and deep expertise in secretory pathway biology, enabling precise, rapid, and repeatable drug discovery. This unique methodology allows Gate Bioscience to address a broad spectrum of diseases using a single therapeutic mechanism, with the potential to revolutionize the treatment of intractable diseases.

Allara is a healthcare program focused on providing specialized virtual care for women dealing with complex chronic health conditions, particularly polycystic ovary syndrome. The platform connects patients with medical providers and registered dietitians, offering a comprehensive approach that includes diagnostic testing, prescriptions, and personalized video consultations. Allara emphasizes holistic care, integrating dietary and lifestyle changes alongside nutrition counseling to help women manage their health effectively. Through its virtual appointments, the program aims to simplify access to expert care, enabling patients to track and improve their overall medical wellbeing.

Midi Health is a virtual care clinic dedicated to addressing the health needs of women, particularly during menopause and related conditions. The clinic specializes in treating issues such as depression, gynecological cancer, and menstrual problems through a clinical platform that delivers personalized care protocols. These protocols are administered by clinicians who are trained in female midlife health. Midi Health enhances its services by utilizing specialized at-home labs, providing prescription medications, supplements, and lifestyle coaching. This comprehensive approach aims to empower women to manage the challenges they face during critical stages of their lives and careers.

Optiwatt is a developer of a monitoring application that helps electric vehicle (EV) owners understand the costs associated with charging their vehicles at home. The platform connects home electricity rate data with EV battery metrics, allowing users to see the cost of each charge and track their electric utility expenses based on their home address. By providing insights into real-time electricity rates, Optiwatt enables users to forecast their charging costs and calculate the savings achieved by driving electric compared to traditional gasoline vehicles. Additionally, the application aims to alleviate range anxiety by offering charge forecasting features, ensuring users are informed about their charging needs and expenses.

EpiBiologics focuses on developing antibody-based targeted therapies aimed at membrane and extracellular proteins that contribute to various diseases. The company utilizes its EpiTAC platform to create therapeutics that degrade these disease-driving proteins, addressing the underlying biology of disorders. By specializing in protein degradation, EpiBiologics enables researchers to manipulate cellular proteostasis, offering potential solutions for a wide range of medical conditions.

Resistant AI specializes in fraud prevention software aimed at safeguarding automated financial systems from manipulation and attacks. The company develops solutions that protect vital processes such as online credit scoring, fraud detection, and anti-money laundering systems from organized fraudsters. By focusing on the risks associated with machine learning and artificial intelligence, Resistant AI assists banks, insurance companies, and e-commerce entities in securing their digital transactions. Their technology enables these organizations to implement identity forensics, thereby enhancing the integrity of automated financial services and mitigating the threats posed by advanced fraud.

Caraway is a digital healthcare company for college women+ that provides integrated mental, reproductive and physical healthcare services. Built with students for students, Caraway arms women+ with the first personalized, equitable and digitally-accessible care solution that prioritizes their needs and concerns. With an unprecedented need for mental health resources and new barriers and persistent inequities in women’s+ health, Caraway provides access to trusted, holistic, and compassionate healthcare so women+ can get the care they need when they need it.

Delve Bio is a biotechnology company focused on delivering molecular insights to enhance precision patient care. It specializes in the pathogen-agnostic and unbiased detection of neuro-infectious pathogens in cerebrospinal fluid (CSF). By providing comprehensive diagnostic solutions in a single test, Delve Bio equips laboratories and clinicians with critical information necessary for identifying both common and rare infectious diseases, thereby facilitating more accurate and timely medical interventions.

Bitterroot Bio is a biotechnology company focused on developing innovative immunotherapy-based treatments for cardiovascular disease. By harnessing the immune system's natural capabilities to combat illness, the company conducts research to understand the significant roles of immune cells and immune modulators in the onset and advancement of cardiovascular conditions. Through its commitment to advancing medical treatments, Bitterroot Bio aims to provide effective therapies that can transform cardiovascular disease management and improve patient outcomes.

Comanche Biopharma is a biopharmaceutical company focused on developing an investigational small interfering RNA (siRNA) medicine aimed at treating preterm preeclampsia. The company is committed to ensuring that all women and their babies have access to safe and effective therapies for life-threatening complications during pregnancy. Comanche Biopharma's mission emphasizes the importance of evidence-based and affordable solutions, enabling women to receive cost-effective treatments that address the root causes of preeclampsia.

Push Security specializes in cybersecurity software that aims to prevent identity-based attacks. Its browser-based agent monitors how employees create and use identities, generating unique telemetry that can be accessed through the Push platform or integrated with existing security information and event management (SIEM) systems. This allows security teams to oversee their entire identity attack surface and effectively detect and block various identity-based threats, including advanced phishing techniques. Push Security enforces preventive measures that guide employees within their browser, helping to avert potential breaches before they occur. The platform also provides clear guidance for implementing essential security controls, with automation facilitating quicker deployment. This approach enables organizations, particularly small and medium-sized enterprises, to enhance their security measures efficiently and affordably without the need for additional solutions.

EpiBiologics focuses on developing antibody-based targeted therapies aimed at membrane and extracellular proteins that contribute to various diseases. The company utilizes its EpiTAC platform to create therapeutics that degrade these disease-driving proteins, addressing the underlying biology of disorders. By specializing in protein degradation, EpiBiologics enables researchers to manipulate cellular proteostasis, offering potential solutions for a wide range of medical conditions.

Dope Security is a stealth technology company focused on developing enterprise cybersecurity software that addresses web-based threats. Its innovative platform eliminates the traditional data center architecture used by legacy providers by implementing a fly-direct approach that secures data directly at the endpoint. This method enhances performance while ensuring privacy and reliability for enterprises. The company aims to provide a seamless user experience, making it easier for cybersecurity firms to protect their clients from various online vulnerabilities.

MedTourEasy, a global healthcare company, provides you the informational resources needed to evaluate your global options. MedTourEasy provides analytical solutions to our partner healthcare providers globally.

Santa Ana Bio is a biotechnology company focused on developing precision therapies for autoimmune and inflammatory diseases. By utilizing advanced technologies such as deep cell profiling, single-cell genomics, and multi-omics platforms, the company designs targeted biologics that aim to provide effective and personalized treatment options. Through its innovative approach, Santa Ana Bio seeks to enhance patient outcomes and improve quality of life for those affected by autoimmune conditions.

Typeface is a generative AI application designed for enterprise content creation, facilitating the development of personalized and on-brand materials. The company offers industry-first self-service solutions that streamline the entire content lifecycle, allowing employees to generate high-quality content quickly and efficiently. By combining content velocity with brand personalization and control, Typeface enables organizations to enhance their content production capabilities, ensuring that all generated materials maintain brand authenticity while meeting the demands of speed and creativity. This innovative platform empowers users at all levels to craft captivating content effortlessly.

Aera Therapeutics is a biotechnology company focused on enhancing the delivery of genetic medicines through its proprietary protein nanoparticle (PNP) platform. This innovative platform utilizes endogenous human proteins to create capsid-like structures that can effectively package and transfer nucleic acid cargo. By addressing the limitations of current delivery technologies, Aera aims to extend the application of genetic medicines across various tissues and disease areas, ultimately benefiting a wider patient population. In addition to its PNP platform, Aera has developed a therapeutic enzyme platform that features novel, compact, and programmable gene-editing enzymes, further advancing its mission to transform the field of genetic medicine.

Superplastic, Inc. is a character-based product and entertainment company founded in 2017 and based in Burlington, Vermont. The company specializes in manufacturing and marketing limited edition art toys, apparel, games, and animation, featuring unique characters created in collaboration with renowned artists. Superplastic leverages the principles of effort and scarcity to enhance the value of its offerings, creating exclusive works of art for a select audience. The company also operates a platform that engages customers through various media, including animated videos and music, enabling interactions with its synthetic superstars in innovative ways. Products are primarily sold online, reflecting a modern approach to retail and entertainment.

Paradigm is rebuilding the clinical research ecosystem by developing a platform that allows all patients equitable access to trials while improving trial efficiency and lowering barriers to participation for healthcare providers. It is an innovative company that is dedicated to transforming the clinical research ecosystem. Their mission is to create a more accessible and equitable healthcare system by developing a platform that enables patients from diverse backgrounds to participate in clinical trials. Clinical trials are essential for testing and developing new drugs, therapies, and medical devices, but historically, they have been plagued by inefficiencies, barriers to access, and inequities in patient representation. Paradigm aims to solve these challenges by creating a platform that uses technology and data-driven insights to streamline the clinical trial process, making it more efficient, cost-effective, and inclusive. The Paradigm platform is designed to facilitate seamless communication and collaboration among all stakeholders involved in clinical research, including patients, healthcare providers, pharmaceutical companies, and regulatory agencies. By leveraging technology such as AI, machine learning, and predictive analytics, Paradigm can identify and match eligible patients to clinical trials, streamline the recruitment and enrollment process, and provide real-time data insights to all stakeholders. Overall, Paradigm's innovative approach to clinical research has the potential to revolutionize the healthcare industry by improving patient outcomes, reducing healthcare costs, and accelerating the development of new treatments and therapies.

Osmo is a company that combines artificial intelligence with olfactory science to create a platform that gives computers a sense of smell. Initially focused on the fragrance industry, Osmo develops aroma molecules for products such as perfumes, shampoos, lotions, and candles. In addition to enhancing consumer experiences, the technology has the potential to detect diseases earlier and track pandemics, ultimately aiming to improve overall health and well-being. By addressing these challenges, Osmo seeks to revolutionize how scent is integrated into everyday life and its implications for human health.

Cacheflow is a zero-code software-as-a-service (SaaS) sales platform that automates the proposal-to-payment process, facilitating a seamless sales experience. Founded in 2021 and based in San Francisco, the company offers a solution that simplifies the SaaS sales flow by integrating various functions into a single platform. Sales teams can quickly generate dynamic quotes and streamline the buying process through features such as simple configuration, interactive checkout, and integrated payment options. Cacheflow's services include self-service checkout, flexible payment plans, and automated billing, all designed to enhance cash flow and improve client relationships, ultimately enabling SaaS businesses to sell more efficiently.

Contraline, Inc. is a biotechnology company based in Charlottesville, Virginia, focused on developing male birth control solutions. The company is creating an innovative, long-lasting, non-hormonal, and reversible contraceptive known as Echo-V. This product consists of an ultrasound-visible polymer solution that is injected into the vas deferens, forming a polymer hydrogel device. This device acts as a semi-permeable membrane, effectively blocking sperm while allowing bodily fluids to pass through. Contraline also offers Vasintomy, a non-surgical procedure for the insertion of Echo-V, providing a cost-effective and user-friendly approach to male contraception. Founded in 2015, Contraline aims to transform male reproductive health through its groundbreaking technology.

SideQuest Ltd is a company based in Belfast, United Kingdom, that specializes in developing a virtual reality platform for computer games. Founded in 2020, SideQuest operates as a community-driven app store, providing users with access to early access content in the realm of virtual reality. This innovative platform allows developers to distribute their games directly to users, fostering a collaborative environment for both creators and players within the growing virtual reality ecosystem.

Pretzel Therapeutics is a biotechnology company focused on developing therapies for mitochondrial dysfunction. Founded by leading experts in mitochondrial biology, the company aims to create innovative treatments that address the underlying causes of mitochondrial issues. By leveraging a comprehensive understanding of mitochondrial mechanisms, Pretzel Therapeutics seeks to reverse dysfunction at its roots, potentially providing effective solutions for patients suffering from a range of conditions, including those related to aging. The company's name reflects its scientific focus on the mitochondrion, which is characterized by its unique and highly folded inner membrane, distinguishing it from other organelles in the body.

Omni is a multifaceted company based in San Francisco, California, that specializes in business intelligence, cybersecurity, and cloud engineering services. Its primary offering is a unique business intelligence platform that merges the reliability of a shared data model with the flexibility of SQL, allowing users to easily access, explore, and share curated data metrics. This platform is designed to streamline the data analytics process, enabling clients to focus on deriving meaningful insights without the complications often associated with data management. Additionally, Omni operates a rentals platform that connects local businesses with community members, providing access to a variety of rental items such as bikes, surfboards, and camping equipment. This initiative enhances community engagement by making diverse products readily available for short-term use.

Twid is India's first rewards-based payment network, established in Bengaluru in October 2020. The platform consolidates various rewards points systems from different issuers into a single application, allowing consumers to access and utilize their rewards from banks, brands, travel, and dining for everyday payments. Twid connects over 50,000 merchants, including offline retailers, online partners, restaurants, and hotel and flight aggregators, creating a comprehensive network for users. The company has partnered with more than 10 issuers and serves a customer base exceeding 40 million. Founded by Amit Koshal, Rishi Batra, and Amit Sharma, Twid aims to make reward points a universal currency, enabling customers to spend their accumulated points freely across multiple platforms.

Vicinitas Therapeutics is a biotech startup that specializes in developing medicines that impact patient lives. Its vision is to use its proprietary Deubiquitinase Targeting Chimera (DUBTAC) platform to restore the levels of aberrantly degraded proteins that cause disease to confer therapeutic benefit.

Xilis, Inc. is a biotechnology company based in Chapel Hill, North Carolina, founded in 2019. It specializes in developing advanced organoid technologies aimed at guiding precision therapy for cancer patients and enhancing drug discovery processes. The company's flagship platform, XilisµO, facilitates rapid diagnostics and personalized drug screening while providing scalable, patient-derived models for high-throughput drug discovery. This technology supports physicians and pharmaceutical companies in creating tailored treatments by enabling effective drug screening, ultimately contributing to more precise and cost-efficient cancer therapies.

Areteia Therapeutics is a biotechnology company focused on improving the management of eosinophilic asthma through an innovative oral drug treatment. The company, which emerged from Knopp, aims to provide patients with a novel therapeutic option that inhibits the maturation of eosinophils—cells that can cause airway damage in asthma patients. Its drug candidate has demonstrated promising results in a phase 2 clinical trial, which showed a reduction in blood eosinophil counts, indicating enhanced lung function. This approach seeks to empower patients by offering a potentially effective and accessible treatment for a severe form of asthma, thereby improving their quality of life and disease management.

FYTO, Inc. is a company based in Cambridge, Massachusetts, that focuses on developing plant-based feed production systems aimed at enhancing the sustainability of agriculture. Founded in 2019, FYTO specializes in creating nutrient-dense crops that require minimal resources, alongside cultivation and harvesting systems designed to ensure quality and consistency. The company's offerings include a variety of agricultural products such as animal feed, plant-based proteins, nutritional supplements, and bio-fertilizers. By adopting climate-friendly practices and methodologies, FYTO aims to support farmers globally in achieving improved economic and environmental outcomes in their agricultural operations.

FlexiDAO is a company that specializes in renewable energy tracking software, leveraging blockchain technology to certify and trace electricity from production to consumption. Its platform allows clients to make credible and verifiable claims about their energy's carbon footprint on an hourly basis. By providing real-time traceability and certification of origin for renewable energy, FlexiDAO enables customers to better understand the source and environmental impact of their energy usage. This capability supports businesses in procuring cleaner electricity and advancing their decarbonization efforts, ultimately making the goal of 24/7 carbon-free energy more attainable.

Sanas is a technology company that specializes in real-time speech-understanding solutions designed to modulate accents while maintaining the natural quality of voices and emotions. Its platform aids multilingual speakers by offering accent correction, which facilitates effective communication and reduces language barriers. The technology is particularly beneficial for contact centers and enterprises, enhancing overall communication, improving customer satisfaction, and minimizing instances of miscommunication. By enabling users to communicate in their preferred accents without noticeable delays, Sanas fosters better understanding and interaction among diverse speakers.

Ahana, founded in 2020 and based in San Mateo, California, specializes in developing ad hoc analytics solutions built on PrestoDB. The company aims to simplify interactive analytics for organizations of various sizes, providing a platform that facilitates efficient data analysis. Recognizing the widespread adoption of Presto in major internet companies, Ahana focuses on bringing these capabilities to a broader audience while actively promoting and supporting the Presto community. Through its offerings, Ahana seeks to enhance the accessibility and usability of ad hoc analytics across diverse sectors.

Strella Biotechnology, Inc. is a Philadelphia-based company that designs and manufactures sensor-based devices aimed at maximizing the freshness of produce throughout the supply chain. Founded in 2018 by Jacob Jordan and Katherine Sizov, the company specializes in ethylene detection technology, which assesses the ripeness of fruit by measuring the ethylene gas emitted during ripening. This innovation helps to optimize the produce supply chain by providing critical data that reduces spoilage and enhances the management of fresh produce. Strella Biotechnology leverages its patented technology to support efficiency and maintain quality in food distribution.

Deepset is a company specializing in natural language processing (NLP) solutions, focusing on leveraging the latest advancements in machine learning to create real-world applications. It is known for developing the Haystack open-source framework, which facilitates the deployment of NLP tasks, and for offering deepset Cloud, a platform designed for enterprise AI teams. Since its inception in 2018, deepset has supported numerous AI teams globally by providing reliable, open-source technology and tailored solutions. The company's software emphasizes the use of transfer learning to enhance model performance while minimizing the amount of training data required, thereby enabling users to unlock value from diverse text sources effectively.

Doppler Technologies, Inc., established in 2018, specializes in developing and operating secret management software solutions. The company's flagship product, Doppler, is a secure software solution designed to store and manage software secrets such as API keys, credentials, environment variables, and database URLs. Doppler's platform is language, stack, and infrastructure agnostic, enhancing developer productivity while bolstering overall security. It securely stores and manages these secrets, enabling developers and security teams to maintain synchronization and security across various devices, environments, and team members.

Waltz Health is focused on enhancing the pharmaceutical supply chain by collaborating with consumers, payers, and pharmacies to develop innovative, technology-driven solutions for pricing, distribution, and prescription of medications. The company creates AI-driven marketplaces that aim to reduce costs and provide valuable insights for users, facilitating informed decision-making in prescription care. By offering consumer tools designed to empower individuals and help payers manage their pharmacy benefits, Waltz Health strives to improve accessibility and affordability in the healthcare sector.

Rooser is a business-to-business platform based in Edinburgh, Scotland, that facilitates seafood trade across Europe. The company provides a cloud-based marketplace specifically for fresh fish, allowing seafood buyers and suppliers to connect and engage in efficient commerce. Rooser's platform simplifies the trading process by enabling users to negotiate prices and manage deliveries effectively, thus enhancing the overall efficiency of seafood transactions in the market.

Gravity Sketch Limited, established in 2014 and based in London, develops innovative 3D creation tools. It offers multi-platform solutions, including Gravity Sketch VR and Gravity Sketch iOS, empowering design teams to create, collaborate, and refine 3D models, geometries, and artwork more efficiently. The company's intuitive tools aim to streamline workflows and enhance productivity across various industries, such as transportation, industrial design, and apparel.

Rattle is a company that specializes in developing integration technology for Salesforce, facilitating seamless interaction between systems and users within platforms such as Slack and Teams. This revenue orchestration platform caters to all customer-facing departments, allowing sales representatives to log calls, track key metrics, and update opportunities with ease. Additionally, it enables account executives and sales development representatives to maintain customer relationship management systems while providing real-time visibility into pipeline reports. This functionality empowers marketing professionals to focus on engaging with customers rather than managing internal processes. Rattle was co-founded in 2020 by Sahil Aggarwal, Apoorva Verma, and Milan Singh.

Agolo, Inc. is a New York-based company that specializes in developing an artificial intelligence platform designed to create real-time summaries from unstructured information. Utilizing machine learning and natural language processing, Agolo's technology transforms messy data into a clean, structured format, enabling various enterprise applications such as business intelligence dashboards and support site augmentation. The platform helps organizations enhance their product quality, reduce support costs, and quickly identify emerging issues by providing clear insights into customer experiences. Established in 2012 and formerly known as Ninoh, Inc., Agolo serves a diverse range of industries, empowering professionals to efficiently analyze large volumes of data and make informed decisions based on comprehensive summaries.

Overview’s inspection systems are built with Deep Learning technology which allows us to find mistakes more consistently and in a wider variety of situations.

Voltron Data is a company that specializes in creating advanced tools for data access and memory computing, aimed at enhancing the data analytics ecosystem. It offers an open-source platform designed to integrate various components of the data analytics landscape by connecting data, hardware, and developers. This platform supports multi-language tools that facilitate faster data interchange and in-memory processing. By focusing on modular and composable analytics building blocks, Voltron Data enables developers, data scientists, and data engineers to streamline their workflows and improve interoperability standards in areas such as data access, preparation, cleaning, analytics, and feature engineering.

Neo.Tax, based in Mountain View, California, offers tax preparation and automation services through its innovative software platform. The company focuses on simplifying the often complex process of applying for the Research and Development (R&D) tax credit, especially in light of recent tax law changes regarding R&D capitalization. By leveraging machine learning algorithms, Neo.Tax automates the collection and organization of data from various sources, including emails, documents, and financial systems, which streamlines the tax filing process. Their platform is designed to assist both early-stage startups and larger public companies, ensuring they are audit-ready and capable of optimizing their tax liability. Through its solutions, Neo.Tax aims to alleviate common challenges faced by finance teams in accurately documenting activities and expenses related to tax credits.

Seismic Therapeutic is a biotechnology company focused on accelerating immunology drug development through the integration of machine learning in the biologics discovery process. Its IMPACT™ platform addresses key challenges in biologics discovery by combining structural biology, protein engineering, and translational immunology. This innovative approach aims to create optimized therapies more efficiently, ultimately benefiting patients with autoimmune diseases and disorders linked to adaptive immune system dysregulation. With a robust pipeline of biologics, Seismic Therapeutic is committed to enhancing the speed and efficacy of drug development in the field of immunology.

TenSixteen Bio is a biotechnology company based in San Francisco that specializes in developing innovative therapeutics for various age-related disorders. The company focuses on leveraging somatic mosaicism and clonal hematopoiesis in its approach to precision medicine, aiming to address complex diseases such as cancer and cardiovascular conditions. By utilizing advanced DNA analysis, TenSixteen Bio seeks to discover and develop new treatments that can enhance the capabilities of pharmaceutical companies in managing these diseases. Co-founded by Foresite Labs, TenSixteen Bio is dedicated to transforming the future of healthcare through its unique therapeutic strategies.

Carry1st is a mobile games publisher focused on social games and interactive content, primarily in frontier markets like Africa. Founded in 2018 by Cordel Robbin-Coker, Lucy Hoffman, and Tino Mundangepfupfu, the company has assembled a diverse team of 29 professionals from 14 countries, drawing talent from notable organizations such as Carlyle, King, and Jumia. Carry1st offers a comprehensive platform for game developers that includes publishing, distribution, localization, user acquisition, marketing, customer experience, and monetization services. This approach enables developers to collaborate with global content owners and tap into previously underserved markets. The company has successfully raised over $10 million in funding, including a recent $7 million Series A led by prominent investors such as Riot Games and Konvoy Ventures. The funds will be utilized to enhance its existing game portfolio, foster new partnerships with international gaming studios, and expand its workforce.

Wonder is a technology company that specializes in gaming and food delivery services. It offers an all-in-one gaming platform for Android mobile devices, enabling users to play, stream, and share games across various devices. Additionally, Wonder operates a food delivery service using trucks that function as mobile restaurants. Customers order food through a mobile app, and the Wonder trucks drive to a location near the user's home to prepare and deliver fresh meals on-site.

Signos is focused on addressing the obesity epidemic by promoting healthy habits and stabilizing glucose levels through an innovative approach that combines continuous glucose monitoring with an AI-powered application. The company's platform offers real-time insights and personalized recommendations aimed at facilitating sustainable weight loss. By utilizing a wearable device alongside its software, Signos allows users to monitor their glucose levels and visualize their metabolism, empowering them to make informed dietary choices. With a significant portion of the American population facing challenges related to weight management, Signos provides a novel solution to help individuals understand their unique physiological responses to food, ultimately supporting their journey toward a healthier lifestyle.

Patina is a healthcare provider focused on enhancing the aging experience for older adults and their families. The company has developed a care model that prioritizes the unique needs and values of this demographic. By offering personalized and on-demand services, Patina aims to create a healthcare experience that is both human-centered and supportive. This approach allows families to actively participate in the care of their loved ones, ensuring that older adults receive the attention and respect they deserve as they navigate the challenges of aging. Patina's mission is to empower individuals to live their best lives and maintain their dignity as they age.

Modern Age is a health and wellness platform focused on improving the aging process for individuals. It offers health monitoring software that employs computer vision and machine learning to assess skin, hair, and bone health. The platform also integrates data collected from smart bands to create a comprehensive digital record of an individual's well-being. By analyzing this information, Modern Age provides personalized insights and treatment recommendations, empowering users to manage their health more effectively and lead healthier lives as they age.

Resistant AI specializes in fraud prevention software aimed at safeguarding automated financial systems from manipulation and attacks. The company develops solutions that protect vital processes such as online credit scoring, fraud detection, and anti-money laundering systems from organized fraudsters. By focusing on the risks associated with machine learning and artificial intelligence, Resistant AI assists banks, insurance companies, and e-commerce entities in securing their digital transactions. Their technology enables these organizations to implement identity forensics, thereby enhancing the integrity of automated financial services and mitigating the threats posed by advanced fraud.

Sprinter Health is a mobile health company that specializes in providing on-demand healthcare services directly to patients' homes. By sending full-time nurses and phlebotomists, known as "Sprinters," the company aims to improve access to preventive care and enhance the overall patient experience. Sprinter Health employs a cost-effective, hybrid care model that facilitates connections between patients and necessary healthcare services, ultimately striving to improve health outcomes and patient satisfaction. This approach allows patients to receive quality medical care in the comfort of their own homes, ensuring convenience and accessibility without compromising on care quality.

Matter is a social reading application based in the United States that focuses on articles, blogs, and newsletters. The platform aims to enhance users' reading experiences by curating and presenting high-quality content, helping them discover better material online. Through its user-friendly interface, Matter facilitates engagement with a diverse range of written works, making it easier for individuals to connect with relevant information and insights.

Vareto is a modern financial planning and analysis platform tailored for strategic finance and business teams, facilitating company planning, reporting, and operational decision-making. Designed for high-growth and enterprise organizations, Vareto provides a customizable and scalable solution that evolves with business needs. Its platform includes automated reporting tools, planning and modeling features, data visualization capabilities, and comprehensive integration of company management functions. By streamlining reporting processes and enhancing collaboration, Vareto empowers executives to make more informed, data-driven decisions to improve business outcomes.

Altana Technologies operates a global supply chain platform that transforms public and non-public data into an intelligent map of the global supply chain. The platform, known as Altana Atlas, connects enterprises, governments, and logistics providers, facilitating collaboration and trust within business networks. It offers trade data management services by integrating internal and external data to provide clean data sets and a real-time view of transactions, ownership, movements, and risks across the global trade network. By leveraging machine learning, Altana enables organizations in both the public and private sectors to enhance the safety, efficiency, and profitability of trade, while promoting a more resilient, secure, inclusive, and sustainable approach to globalization.

Ahana, founded in 2020 and based in San Mateo, California, specializes in developing ad hoc analytics solutions built on PrestoDB. The company aims to simplify interactive analytics for organizations of various sizes, providing a platform that facilitates efficient data analysis. Recognizing the widespread adoption of Presto in major internet companies, Ahana focuses on bringing these capabilities to a broader audience while actively promoting and supporting the Presto community. Through its offerings, Ahana seeks to enhance the accessibility and usability of ad hoc analytics across diverse sectors.

Nym Health Inc., established in 2017 and headquartered in Boston, Massachusetts, specializes in medical coding technology for healthcare facilities. Its core product, Nym, automates revenue cycle management by interpreting clinical language in patient charts and accurately assigning medical charge codes, reducing operational expenses, improving payment cycles, and enhancing audit readiness. Nym's solution identifies relevant clinical aspects, assigns codes, and provides an audit trail explaining its coding decisions. The company also has a research and development center in Tel Aviv-Yafo, Israel.

Xilis, Inc. is a biotechnology company based in Chapel Hill, North Carolina, founded in 2019. It specializes in developing advanced organoid technologies aimed at guiding precision therapy for cancer patients and enhancing drug discovery processes. The company's flagship platform, XilisµO, facilitates rapid diagnostics and personalized drug screening while providing scalable, patient-derived models for high-throughput drug discovery. This technology supports physicians and pharmaceutical companies in creating tailored treatments by enabling effective drug screening, ultimately contributing to more precise and cost-efficient cancer therapies.

Dyno Therapeutics Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative adeno-associated virus (AAV) vectors for gene therapy applications. Founded in 2018, the company employs an artificial intelligence-powered platform that integrates next-generation DNA synthesis, high-throughput sequencing, and machine learning. This advanced approach allows Dyno Therapeutics to design and optimize cell-targeting capsids, which are crucial for the effective and safe delivery of gene therapies. By leveraging its technology, the company aims to provide medical researchers with novel AAV vectors that enhance the efficacy of in vivo therapeutic solutions.

Nearby is a computer software company that facilitates connections between local businesses and nearby customers. The company provides a platform that enables merchants to showcase their inventory online, effectively bringing their products into a digital marketplace tailored to their local community. By generating demand and fulfilling orders through targeted email campaigns, local delivery, and nationwide shipping, Nearby empowers local merchants to enhance their visibility and grow their customer base.

Treeline Biosciences is a biotechnology company established in 2021 and based in Stamford, Connecticut. The company focuses on developing transformative precision medicines aimed at treating cancer and other serious health conditions. Utilizing a comprehensive drug discovery platform, Treeline combines mechanistic biology, medicinal chemistry, computational science, structural biology, and protein science to create innovative therapeutic solutions. Through its research and development efforts, Treeline aims to provide effective treatments to improve patient outcomes in oncology and beyond.

Inkxpert Inc. is a marketing communications company that specializes in creating high-quality content tailored to various industries, including technology, healthcare, automobile, sports, lifestyle, fashion, education, and travel. The company focuses on understanding clients' products to design effective content for their marketing needs. Inkxpert offers a range of services, including technical research, content writing for marketing materials and websites, search engine optimization, social media management, case studies, and whitepapers. Each client is assigned a dedicated technical writing team, ensuring a quick turnaround time for project delivery, editing, and publishing.

DotPe is a technology startup based in Gurgaon, Haryana, India, founded in 2019 by Anurag Gupta, Gyanesh Sharma, and Shailaz Nag. The company operates a commerce and payments platform designed to enhance customer engagement and streamline the payment experience for offline enterprises. By providing tools for catalog discovery, customer management, order management, website management, and logistics, DotPe empowers businesses to transition to digital sales effectively. Its solutions aim to help offline businesses increase their sales, improve operational efficiency, and foster direct interactions with customers, thereby facilitating their digital transformation in an increasingly competitive marketplace.

Leyden Labs is a biotechnology company focused on developing intranasal products aimed at protecting individuals from respiratory viruses. By targeting commonalities among various viral families, Leyden Labs seeks to provide broad-spectrum protection against multiple strains of viruses, including those in the influenza and coronavirus families. Unlike traditional vaccines that typically address specific variants, Leyden Labs' innovative approach allows for simultaneous protection against a range of viruses, thereby empowering individuals to safeguard their health and prevent the transmission of diseases. The company's team comprises experienced biotechnology professionals and new talent, all committed to advancing solutions that alleviate the impact of respiratory infections on global health.